Report

  1. Home
  2. Market Research Future

Dercum's Disease Market Research Report Forecast till 2030

Market Report I 2023-11-01 I 115 Pages I Market Research Future

Dercum's Disease Market Research Report Forecast till 2030
Market Overview
The Dercum's Disease Market is anticipated to register a CAGR of 6.76% during the forecast period. The rising predominance of interesting diseases and expanding research and advancement exercises are driving market development.
Uncommon diseases, for example, adiposis dolorosa, and lipomas alongside the continuous Coronavirus pandemic, represent a significant weight worldwide. As per the NCBI study, held in February 2021, roughly 2500 individuals each year with free connective (fat) tissue disease were seen, most patients with lipedema, six patients with FML-Type DD, and 10 patients with angiolipoma-type Dercum's disease. Moreover, a similar review recommended that the predominance of Dercum's disease is 0.64% in the populace, and the commonness of lipedema in the USA is believed to be 11% in ladies however the reach is 5 to 39%. A greater part of individuals with dercum's disease are ladies.
Besides, dercum's disease is portrayed by various, agonizing developments of greasy tissue (lipomas). In this way, the quantity of patients experiencing uncommon diseases is expanding universally. Besides, the rising instances of Coronavirus likewise fundamentally affect the market development of the dercum's disease. Such an ascent in the quantity of diseases cases is expected to worldwide expand the interest for dercum's disease.
Market Segmentation
The Market segments of Dercum's Disease, based on treatment, includes surgery, medication, liposuction, electrotherapy, acupuncture, and others.
The Dercum's Disease Market segmentation is based on end user that includes hospital & clinics ambulatory surgical centers others. Based on distribution channel the market is divided into hospital pharmacies, retail pharmacies, and others.
Regional Insights

The North America dercum's disease market represented the biggest market share in 2022. This is because of the ideal government act towards for the improvement of uncommon disease drug and gadgets as well as endorsement of medication in the district.
Europe dercum's disease market represents the second-biggest market share because of the research concentrates on through medical services administrative bodies for the therapy of dercum's disease and ideal approach and public undertakings systems. further, the Germany market of dercum's disease was credited to hold the biggest market share, and the France market of dercum's disease is supposed to quickest developing market in the European locale.
The Asia-Pacific dercum's disease market is supposed to develop at a critical offer from 2023 to 2030. This is because of the rising speculation, clinical preliminary examinations, and organizations' Research and development for medications to treat fat dolorosa in the Asia-Pacific locale.
The Rest of the World is portioned into the Middle East, Africa, and Latin America. The market of dercum's disease in the previously mentioned locales is probably going to observe development because of raising of assets and interests in the area through organizations.

Major Players
Key Companies in the market of dercum's disease include Pfizer Inc (US), Abbvie, Inc (US), Johnson & Johnson Services, Inc (US), GlaxoSmithKline plc (UK), Bausch & Lomb Incorporated (Canada), Caliway (Taiwan), Raziel Therapeutics Ltd (Israel), Nivarta, Inc (US), BHR Pharmaceuticals Ltd (UK), and Novartis International AG (Switzerland).

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 DEFINITION

2.2 SCOPE OF THE STUDY

2.3 RESEARCH OBJECTIVE

2.4 LIST OF ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

3.1 DATA MINING

3.2 SECONDARY RESEARCH

3.3 PRIMARY RESEARCH

3.3.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS

3.3.2 BREAKDOWN OF PRIMARY RESPONDENTS

3.4 FORECASTING TECHNIQUES

3.5 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION

3.5.1 BOTTOM-UP APPROACH

3.5.2 TOP-DOWN APPROACH

3.6 DATA TRIANGULATION

3.7 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW

4.2 DRIVERS

4.2.1 RISING PREVALENCE OF RARE DISEASES

4.2.2 INCREASING RESEARCH AND DEVELOPMENT ACTIVITIES

4.3 RESTRAINTS

4.3.1 LACK OF AWARENESS AMONG THE PEOPLE ABOUT THE DISEASE

4.4 OPPORTUNITIES

4.4.1 RISING NUMBER OF STRATEGIC INITIATIVES

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS

5.1.1 R&D

5.1.2 MANUFACTURING

5.1.3 SALES AND DISTRIBUTION

5.1.4 POST-SALES REVIEW

5.2 PORTER'S FIVE FORCES MODEL

5.2.1 THREAT OF NEW ENTRANTS

5.2.2 BARGAINING POWER OF SUPPLIERS

5.2.3 THREAT OF SUBSTITUTES

5.2.4 BARGAINING POWER OF BUYERS

5.2.5 INTENSITY OF RIVALRY

5.3 IMPACT OF COVID-19 ON THE GLOBAL DERCUM'S DISEASE MARKET

5.3.1 IMPACT ON SUPPLY CHAIN

5.3.2 IMPACT ON DEMAND

5.3.3 IMPACT ON MARKET

6 GLOBAL DERCUM'S DISEASE MARKET, BY TREATMENT

6.1 OVERVIEW

6.2 SURGERY

6.3 MEDICATION

6.3.1 DIURETICS

6.3.2 NON-STEROIDAL ANTI-INFLAMMATORY DRUG

6.3.3 CORTICOSTEROIDS

6.3.4 OTHERS

6.4 LIPOSUCTION

6.5 ELECTROTHERAPY

6.6 ACUPUNCTURE

6.7 OTHERS

7 GLOBAL DERCUM'S DISEASE MARKET, BY END-USER

7.1 OVERVIEW

7.2 HOSPITAL & CLINICS

7.3 AMBULATORY SURGICAL CENTERS

7.4 OTHERS

8 GLOBAL DERCUM'S DISEASE MARKET, BY DISTRIBUTION CHANNEL

8.1 OVERVIEW

8.2 HOSPITAL PHARMACIES

8.3 RETAIL PHARMACIES

8.4 OTHERS

9 GLOBAL DERCUM'S DISEASE MARKET, BY REGION

9.1 OVERVIEW

9.2 NORTH AMERICA

9.2.1 US

9.2.2 CANADA

9.3 EUROPE

9.3.1 GERMANY

9.3.2 UK

9.3.3 FRANCE

9.3.4 ITALY

9.3.5 SPAIN

9.3.6 REST OF EUROPE

9.4 ASIA PACIFIC

9.4.1 CHINA

9.4.2 INDIA

9.4.3 INDIA

9.4.4 AUSTRALIA

9.4.5 SOUTH KOREA

9.4.6 REST OF ASIA PACIFIC

9.5 REST OF THE WORLD

9.5.1 MIDDLE EAST

9.5.2 AFRICA

9.5.3 LATIN AMERICA

10 COMPETITIVE LANDSCAPE

10.1 OVERVIEW

10.2 COMPETITIVE BENCHMARKING

10.3 FINANCIAL MATRIX

10.3.1 SALES (USD MILLION), 2022

10.3.2 R&D EXPENDITURE (USD MILLION), 2022

11 COMPANY PROFILES

11.1 PFIZER INC

11.1.1 COMPANY OVERVIEW

11.1.2 FINANCIAL OVERVIEW

11.1.3 PRODUCTS OFFERED

11.1.4 KEY DEVELOPMENTS

11.1.5 SWOT ANALYSIS

11.1.6 KEY STRATEGIES

11.2 ABBVIE, INC

11.2.1 COMPANY OVERVIEW

11.2.2 FINANCIAL OVERVIEW

11.2.3 PRODUCTS OFFERED

11.2.4 KEY DEVELOPMENTS

11.2.5 KEY STRATEGIES

11.3 JOHNSON & JOHNSON SERVICES, INC

11.3.1 COMPANY OVERVIEWS

11.3.2 FINANCIAL OVERVIEW

11.3.3 PRODUCTS OFFERED

11.3.4 KEY DEVELOPMENTS

11.3.5 SWOT ANALYSIS

11.3.6 KEY STRATEGIES

11.4 GLAXOSMITHKLINE PLC

11.4.1 COMPANY OVERVIEW

11.4.2 FINANCIAL OVERVIEW

11.4.3 PRODUCTS OFFERED

11.4.4 KEY DEVELOPMENTS

11.4.5 SWOT ANALYSIS

11.4.6 KEY STRATEGIES

11.5 BAUSCH & LOMB INCORPORATED

11.5.1 COMPANY OVERVIEW

11.5.2 FINANCIAL OVERVIEW

11.5.3 PRODUCTS OFFERED

11.5.4 KEY DEVELOPMENTSS

11.5.5 KEY STRATEGIES

11.6 CALIWAY

11.6.1 COMPANY OVERVIEW

11.6.2 FINANCIAL OVERVIEW

11.6.3 PRODUCTS/SERVICES OFFERED

11.6.4 KEY DEVELOPMENTS

11.6.5 KEY STRATEGIES

11.7 RAZIEL THERAPEUTICS LTD

11.7.1 COMPANY OVERVIEW

11.7.2 FINANCIAL OVERVIEW

11.7.3 PRODUCTS OFFERED

11.7.4 KEY DEVELOPMENTS

11.7.5 KEY STRATEGIES

11.8 NIVARTA, INC.

11.8.1 COMPANY OVERVIEW

11.8.2 FINANCIAL OVERVIEW

11.8.3 PRODUCTS OFFERED

11.8.4 KEY DEVELOPMENTS

11.8.5 SWOT ANALYSIS

11.8.6 KEY STRATEGIES

11.9 BHR PHARMACEUTICALS LTD

11.9.1 COMPANY OVERVIEW

11.9.2 FINANCIAL OVERVIEW

11.9.3 PRODUCTS OFFERED

11.9.4 KEY STRATEGIES

11.10 NOVARTIS INTERNATIONAL AG

11.10.1 COMPANY OVERVIEW

11.10.2 FINANCIAL OVERVIEW

11.10.3 PRODUCTS OFFERED

11.10.4 KEY DEVELOPMENTS

11.10.5 SWOT ANALYSIS

11.10.6 KEY STRATEGIES

12 APPENDIX

12.1 REFERENCES

12.2 RELATED REPORTS

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS

TABLE 2 GLOBAL: DERCUM'S DISEASE MARKET, BY TREATMENT, 2018-2030 (USD MILLION)

TABLE 3 GLOBAL: DERCUM'S DISEASE MARKET, FOR SURGERY, BY REGION, 2018-2030 (USD MILLION)

TABLE 4 GLOBAL: DERCUM'S DISEASE MARKET, FOR MEDICATION, BY REGION, 2018-2030 (USD MILLION)

TABLE 5 GLOBAL: DERCUM'S DISEASE MARKET, FOR MEDICATION, BY TYPE, 2018-2030 (USD MILLION)

TABLE 6 GLOBAL: DERCUM'S DISEASE MARKET, FOR DIURETICS, BY REGION, 2018-2030 (USD MILLION)

TABLE 7 GLOBAL: DERCUM'S DISEASE MARKET, FOR NON-STEROIDAL ANTI-INFLAMMATORY DRUG, BY REGION, 2018-2030 (USD MILLION)

TABLE 8 GLOBAL: DERCUM'S DISEASE MARKET, FOR CORTICOSTEROIDS, BY REGION, 2018-2030 (USD MILLION)

TABLE 9 GLOBAL: DERCUM'S DISEASE MARKET, FOR OTHERS, BY REGION, 2018-2030 (USD MILLION)

TABLE 10 GLOBAL: DERCUM'S DISEASE MARKET, FOR LIPOSUCTION, BY REGION, 2018-2030 (USD MILLION)

TABLE 11 GLOBAL: DERCUM'S DISEASE MARKET, FOR ELECTROTHERAPY, BY REGION, 2018-2030 (USD MILLION)

TABLE 12 GLOBAL: DERCUM'S DISEASE MARKET, FOR ACUPUNCTURE, BY REGION, 2018-2030 (USD MILLION)

TABLE 13 GLOBAL: DERCUM'S DISEASE MARKET, FOR OTHERS, BY REGION, 2018-2030 (USD MILLION)

TABLE 14 GLOBAL: DERCUM'S DISEASE MARKET, BY END-USER, 2018-2030 (USD MILLION)

TABLE 15 GLOBAL: DERCUM'S DISEASE MARKET, FOR HOSPITAL & CLINICS, BY REGION, 2018-2030 (USD MILLION)

TABLE 16 GLOBAL: DERCUM'S DISEASE MARKET, FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)

TABLE 17 GLOBAL: DERCUM'S DISEASE MARKET, FOR OTHERS, BY REGION, 2018-2030 (USD MILLION)

TABLE 18 GLOBAL: DERCUM'S DISEASE MARKET, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)

TABLE 19 GLOBAL: DERCUM'S DISEASE MARKET, FOR HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)

TABLE 20 GLOBAL: DERCUM'S DISEASE MARKET, FOR RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)

TABLE 21 GLOBAL: DERCUM'S DISEASE MARKET, FOR OTHERS, BY REGION, 2018-2030 (USD MILLION)

TABLE 22 GLOBAL: DERCUM'S DISEASE MARKET, BY REGION, 2018-2030 (USD MILLION)

TABLE 23 NORTH AMERICA: DERCUM'S DISEASE MARKET, BY COUNTRY, 2018-2030 (USD MILLION)

TABLE 24 NORTH AMERICA: DERCUM'S DISEASE MARKET, BY TREATMENT, 2018-2030 (USD MILLION)

TABLE 25 NORTH AMERICA: DERCUM'S DISEASE MARKET, BY MEDICATION, 2018-2030 (USD MILLION)

TABLE 26 NORTH AMERICA: DERCUM'S DISEASE MARKET, BY END-USER, 2018-2030 (USD MILLION)

TABLE 27 NORTH AMERICA: DERCUM'S DISEASE MARKET, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)

TABLE 28 US: DERCUM'S DISEASE MARKET, BY TREATMENT, 2018-2030 (USD MILLION)

TABLE 29 US: DERCUM'S DISEASE MARKET, BY MEDICATION, 2018-2030 (USD MILLION)

TABLE 30 US: DERCUM'S DISEASE MARKET, BY END-USER, 2018-2030 (USD MILLION)

TABLE 31 US: DERCUM'S DISEASE MARKET, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)

TABLE 32 CANADA: DERCUM'S DISEASE MARKET, BY TREATMENT, 2018-2030 (USD MILLION)

TABLE 33 CANADA: DERCUM'S DISEASE MARKET, BY MEDICATION, 2018-2030 (USD MILLION)

TABLE 34 CANADA: DERCUM'S DISEASE MARKET, BY END-USER, 2018-2030 (USD MILLION)

TABLE 35 CANADA: DERCUM'S DISEASE MARKET, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)

TABLE 36 EUROPE: DERCUM'S DISEASE MARKET, BY COUNTRY, 2018-2030 (USD MILLION)

TABLE 37 EUROPE: DERCUM'S DISEASE MARKET, BY TREATMENT, 2018-2030 (USD MILLION)

TABLE 38 EUROPE: DERCUM'S DISEASE MARKET, BY MEDICATION, 2018-2030 (USD MILLION)

TABLE 39 EUROPE: DERCUM'S DISEASE MARKET, BY END-USER, 2018-2030 (USD MILLION)

TABLE 40 EUROPE: DERCUM'S DISEASE MARKET, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)

TABLE 41 GERMANY: DERCUM'S DISEASE MARKET, BY TREATMENT, 2018-2030 (USD MILLION)

TABLE 42 GERMANY: DERCUM'S DISEASE MARKET, BY MEDICATION, 2018-2030 (USD MILLION)

TABLE 43 GERMANY: DERCUM'S DISEASE MARKET, BY END-USER, 2018-2030 (USD MILLION)

TABLE 44 GERMANY: DERCUM'S DISEASE MARKET, BY DISTRIBUTIONCHANNEL, 2018-2030 (USD MILLION)

TABLE 45 UK: DERCUM'S DISEASE MARKET, BY TREATMENT, 2018-2030 (USD MILLION)

TABLE 46 UK: DERCUM'S DISEASE MARKET, BY MEDICATION, 2018-2030 (USD MILLION)

TABLE 47 UK: DERCUM'S DISEASE MARKET, BY END-USER, 2018-2030 (USD MILLION)

TABLE 48 UK: DERCUM'S DISEASE MARKET, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)

TABLE 49 FRANCE: DERCUM'S DISEASE MARKET, BY TREATMENT, 2018-2030 (USD MILLION)

TABLE 50 FRANCE: DERCUM'S DISEASE MARKET, BY MEDICATION, 2018-2030 (USD MILLION)

TABLE 51 FRANCE: DERCUM'S DISEASE MARKET, BY END-USER, 2018-2030 (USD MILLION)

TABLE 52 FRANCE: DERCUM'S DISEASE MARKET, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)

TABLE 53 ITALY: DERCUM'S DISEASE MARKET, BY TREATMENT, 2018-2030 (USD MILLION)

TABLE 54 ITALY: DERCUM'S DISEASE MARKET, BY MEDICATION, 2018-2030 (USD MILLION)

TABLE 55 ITALY: DERCUM'S DISEASE MARKET, BY END-USER, 2018-2030 (USD MILLION)

TABLE 56 ITALY: DERCUM'S DISEASE MARKET, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)

TABLE 57 SPAIN: DERCUM'S DISEASE MARKET, BY TREATMENT, 2018-2030 (USD MILLION)

TABLE 58 SPAIN: DERCUM'S DISEASE MARKET, BY MEDICATION, 2018-2030 (USD MILLION)

TABLE 59 SPAIN: DERCUM'S DISEASE MARKET, BY END-USER, 2018-2030 (USD MILLION)

TABLE 60 SPAIN: DERCUM'S DISEASE MARKET, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)

TABLE 61 REST OF EUROPE: DERCUM'S DISEASE MARKET, BY TREATMENT, 2018-2030 (USD MILLION)

TABLE 62 REST OF EUROPE: DERCUM'S DISEASE MARKET, BY MEDICATION, 2018-2030 (USD MILLION)

TABLE 63 REST OF EUROPE: DERCUM'S DISEASE MARKET, BY END-USER, 2018-2030 (USD MILLION)

TABLE 64 REST OF EUROPE: DERCUM'S DISEASE MARKET, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)

TABLE 65 ASIA PACIFIC: DERCUM'S DISEASE MARKET, BY COUNTRY, 2018-2030 (USD MILLION)

TABLE 66 ASIA PACIFIC: DERCUM'S DISEASE MARKET, BY TREATMENT, 2018-2030(USD MILLION)

TABLE 67 ASIA PACIFIC: DERCUM'S DISEASE MARKET, BY MEDICATION, 2018-2030(USD MILLION)

TABLE 68 ASIA PACIFIC: DERCUM'S DISEASE MARKET, BY END-USER, 2018-2030(USD MILLION)

TABLE 69 ASIA PACIFIC: DERCUM'S DISEASE MARKET, BY DISTRIBUTION CHANNEL, 2018-2030(USD MILLION)

TABLE 70 CHINA: DERCUM'S DISEASE MARKET, BY TREATMENT, 2018-2030(USD MILLION)

TABLE 71 CHINA: DERCUM'S DISEASE MARKET, BY MEDICATION, 2018-2030(USD MILLION)

TABLE 72 CHINA: DERCUM'S DISEASE MARKET, BY END-USER, 2018-2030(USD MILLION)

TABLE 73 CHINA: DERCUM'S DISEASE MARKET, BY DISTRIBUTION CHANNEL, 2018-2030(USD MILLION)

TABLE 74 INDIA: DERCUM'S DISEASE MARKET, BY TREATMENT, 2018-2030(USD MILLION)

TABLE 75 INDIA: DERCUM'S DISEASE MARKET, BY MEDICATION, 2018-2030(USD MILLION)

TABLE 76 INDIA: DERCUM'S DISEASE MARKET, BY END-USER, 2018-2030(USD MILLION)

TABLE 77 CHINA: DERCUM'S DISEASE MARKET, BY DISTRIBUTION CHANNEL, 2018-2030(USD MILLION)

TABLE 78 JAPAN: DERCUM'S DISEASE MARKET, BY TREATMENT, 2018-2030(USD MILLION)

TABLE 79 JAPAN: DERCUM'S DISEASE MARKET, BY MEDICATION, 2018-2030(USD MILLION)

TABLE 80 JAPAN: DERCUM'S DISEASE MARKET, BY END-USER, 2018-2030(USD MILLION)

TABLE 81 JAPAN: DERCUM'S DISEASE MARKET, BY DISTRIBUTION CHANNEL, 2018-2030(USD MILLION)

TABLE 82 AUSTRALIA: DERCUM'S DISEASE MARKET, BY TREATMENT, 2018-2030(USD MILLION)

TABLE 83 AUSTRALIA: DERCUM'S DISEASE MARKET, BY MEDICATION, 2018-2030(USD MILLION)

TABLE 84 AUSTRALIA: DERCUM'S DISEASE MARKET, BY END-USER, 2018-2030(USD MILLION)

TABLE 85 AUSTRALIA: DERCUM'S DISEASE MARKET, BY DISTRIBUTION CHANNEL, 2018-2030(USD MILLION)

TABLE 86 SOUTH KOREA: DERCUM'S DISEASE MARKET, BY TREATMENT, 2018-2030(USD MILLION)

TABLE 87 SOUTH KOREA: DERCUM'S DISEASE MARKET, BY MEDICATION, 2018-2030(USD MILLION)

TABLE 88 SOUTH KOREA: DERCUM'S DISEASE MARKET, BY END-USER, 2018-2030(USD MILLION)

TABLE 89 SOUTH KOREA: DERCUM'S DISEASE MARKET, BY DISTRIBUTION CHANNEL, 2018-2030(USD MILLION)

TABLE 90 REST OF ASIA PACIFIC: DERCUM'S DISEASE MARKET, BY TREATMENT, 2018-2030(USD MILLION)

TABLE 91 REST OF ASIA PACIFIC: DERCUM'S DISEASE MARKET, BY MEDICATION, 2018-2030(USD MILLION)

TABLE 92 REST OF ASIA PACIFIC: DERCUM'S DISEASE MARKET, BY END-USER, 2018-2030(USD MILLION)

TABLE 93 REST OF ASIA PACIFIC: DERCUM'S DISEASE MARKET, BY DISTRIBUTION CHANNEL, 2018-2030(USD MILLION)

TABLE 94 REST OF THE WORLD: DERCUM'S DISEASE MARKET, BY REGION, 2018-2030(USD MILLION)

TABLE 95 REST OF THE WORLD: DERCUM'S DISEASE MARKET, BY TREATMENT, 2018-2030(USD MILLION)

TABLE 96 REST OF THE WORLD: DERCUM'S DISEASE MARKET, BY MEDICATION, 2018-2030(USD MILLION)

TABLE 97 REST OF THE WORLD: DERCUM'S DISEASE MARKET, BY END-USER, 2018-2030(USD MILLION)

TABLE 98 REST OF THE WORLD: DERCUM'S DISEASE MARKET, BY DISTRIBUTION CHANNEL, 2018-2030(USD MILLION)

TABLE 99 MIDDLE EAST: DERCUM'S DISEASE MARKET, BY TREATMENT, 2018-2030(USD MILLION)

TABLE 100 MIDDLE EAST: DERCUM'S DISEASE MARKET, BY MEDICATION, 2018-2030(USD MILLION)

TABLE 101 MIDDLE EAST: DERCUM'S DISEASE MARKET, BY END-USER, 2018-2030(USD MILLION)

TABLE 102 MIDDLE EAST: DERCUM'S DISEASE MARKET, BY DISTRIBUTION CHANNEL, 2018-2030(USD MILLION)

TABLE 103 AFRICA: DERCUM'S DISEASE MARKET, BY TREATMENT, 2018-2030(USD MILLION)

TABLE 104 AFRICA: DERCUM'S DISEASE MARKET, BY MEDICATION, 2018-2030(USD MILLION)

TABLE 105 AFRICA: DERCUM'S DISEASE MARKET, BY END-USER, 2018-2030(USD MILLION)

TABLE 106 AFRICA: DERCUM'S DISEASE MARKET, BY DISTRIBUTION CHANNEL, 2018-2030(USD MILLION)

TABLE 107 LATIN AMERICA: DERCUM'S DISEASE MARKET, BY TREATMENT, 2018-2030(USD MILLION)

TABLE 108 LATIN AMERICA: DERCUM'S DISEASE MARKET, BY MEDICATION, 2018-2030(USD MILLION)

TABLE 109 LATIN AMERICA: DERCUM'S DISEASE MARKET, BY END-USER, 2018-2030(USD MILLION)

TABLE 110 LATIN AMERICA: DERCUM'S DISEASE MARKET, BY DISTRIBUTION CHANNEL, 2018-2030(USD MILLION)

TABLE 111 MAJOR PLAYERS IN THE GLOBAL DERCUM'S DISEASE MARKET

TABLE 112 PFIZER INC: PRODUCTS OFFERED

TABLE 113 ABBVIE, INC: PRODUCTS OFFERED

TABLE 114 JOHNSON & JOHNSON SERVICES, INC: PRODUCTS OFFERED

TABLE 115 GLAXOSMITHKLINE PLC: PRODUCTS OFFERED

TABLE 116 BAUSCH & LOMB INCORPORATED: PRODUCTS OFFERED

TABLE 117 3M: PRODUCTS/SERVICES OFFERED

TABLE 118 RAZIEL THERAPEUTICS LTD: PRODUCTS OFFERED

TABLE 119 NIVARTA, INC: PRODUCTS OFFERED

TABLE 120 BHR PHARMACEUTICALS LTD: PRODUCTS OFFERED

TABLE 121 NOVARTIS INTERNATIONAL AG: PRODUCTS OFFERED

LIST OF FIGURES

FIGURE 1 MARKET SYNOPSIS

FIGURE 2 GLOBAL DERCUM'S DISEASE MARKET STRUCTURE

FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES

FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL DERCUM'S DISEASE MARKET

FIGURE 5 DRIVER IMPACT ANALYSIS

FIGURE 6 RESTRAINT IMPACT ANALYSIS

FIGURE 7 VALUE CHAIN ANALYSIS: GLOBAL DERCUM'S DISEASE MARKET

FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: GLOBAL DERCUM'S DISEASE MARKET

FIGURE 9 GLOBAL: DERCUM'S DISEASE MARKET, BY TREATMENT, 2022 & 2030 (USD MILLION)

FIGURE 10 GLOBAL: DERCUM'S DISEASE MARKET, BY END-USER, 2022 & 2030 (USD MILLION)

FIGURE 11 GLOBAL: DERCUM'S DISEASE MARKET, BY DISTRIBUTIONCHANNEL, 2022 & 2030 (USD MILLION)

FIGURE 12 GLOBAL: DERCUM'S DISEASE MARKET, BY REGION 2022 & 2030 (USD MILLION)

FIGURE 13 GLOBAL: DERCUM'S DISEASE MARKET SHARE (%), BY REGION, 2022

FIGURE 14 NORTH AMERICA: DERCUM'S DISEASE MARKET, BY COUNTRY 2022 & 2030 (USD MILLION)

FIGURE 15 NORTH AMERICA: DERCUM'S DISEASE MARKET SHARE (%), BY COUNTRY 2022

FIGURE 16 EUROPE: DERCUM'S DISEASE MARKET, BY COUNTRY 2022 & 2030 (USD MILLION)

FIGURE 17 EUROPE: DERCUM'S DISEASE MARKET SHARE (%), BY COUNTRY 2022

FIGURE 18 ASIA PACIFIC DERCUM'S DISEASE MARKET SHARE, BY COUNTRY 2022 & 2030 (USD MILLION)

FIGURE 19 ASIA PACIFIC: DERCUM'S DISEASE MARKET SHARE (%), BY COUNTRY, 2022

FIGURE 20 REST OF THE WORLD DERCUM'S DISEASE MARKET SHARE, BY REGION 2022 & 2030 (USD MILLION)

FIGURE 21 REST OF THE WORLD: DERCUM'S DISEASE MARKET SHARE (%), BY REGION, 2022

FIGURE 22 BENCHMARKING OF MAJOR COMPETITORS

FIGURE 23 SALES (USD MILLION), 2022

FIGURE 24 R&D EXPENDITURE (USD MILLION), 2022

FIGURE 25 PFIZER INC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 26 PFIZER INC: SWOT ANALYSIS

FIGURE 27 ABBVIE, INC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 28 JOHNSON & JOHNSON SERVICES, INC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 29 JOHNSON & JOHNSON SERVICES, INC.: SWOT ANALYSIS

FIGURE 30 GLAXOSMITHKLINE PLC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 31 GLAXOSMITHKLINE PLC: SWOT ANALYSIS

FIGURE 32 BAUSCH & LOMB INCORPORATED: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 33 NIVARTA, INC: SWOT ANALYSIS

FIGURE 34 NOVARTIS INTERNATIONAL AG: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 35 NOVARTIS INTERNATIONAL AG: SWOT ANALYSIS

  • Not Sure / Need Reassuring
    • Confirm Content

      • Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:

        Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.

        Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.

        Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.

    • Sample Pages

      • With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.

        It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.

        To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Check for Alternatives

      • Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.

        To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.

  • Prices / Formats / Delivery
    • Prices

      • All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.

        Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Discounts

      • As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.

        Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.

        To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Available Currencies

      • Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.

        Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.

        To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.

    • Licenses

      • License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Global Site License

      • The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.

        It is important to note that this may exclude Parent Companies or Subsidiaries.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Formats

      • The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.

        If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.

    • Delivery

      • Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.

        Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.

        If a delay in delivery is expected you will be informed about it immediately.

    • Shipping Charges

      • As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.

        If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.

  • Ordering
    • By Credit Card

      • We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.

        Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.

        For more information on PayU please visit: https://www.payu.pl/en/about-us

    • By Money Transfer

      • If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.

        With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.

  • Security
    • Website security

      • We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.

        Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.

    • Credit Card Security

      • We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.

        PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.

PLEASE SELECT LICENSE

Related Reports

Military Data Links Market Research Report: By Platform (Ground, Airborne, Naval, Unmanned Systems, and Weapons), by Application (Command and Control, Intelligence, Surveillance, & Reconnaissance, and Radio Communications), by Component (Terminals, Radio Sets, Modems, Routers, Controllers, Transceivers, Monitors, and Others), by Band (Ka/K Band, X-Band (Air to Ground), Ku Band, S-Band, C-Band, L-Band, HF Band, VHF Band, and UHF Band), by Frequency (High Frequency, and Ultra-High Frequency), by Link Type (Link 11, Link 16, Link 22, JREAP-A, JREAP-C, and VMF), by Point-of-Sale (OEM, and Aftermarket), by Military Standard (MIL STD 6011, MIL STD 6016, MIL STD 6017, MIL STD 6020, and MIL STD 3011), and By Region (North America, Europe, Asia-Pacific, Middle East and Africa, South & Central America) Market Forecast Till 2032
 Market Report I 2025-04-21 I 307 Pages
Asia-Pacific Cancer Biomarker Testing Market Research Report by Type (Product and Services), by Testing Type (Single Gene Testing and Multiple Gene Testing), by Region (China, India, Japan, South Korea, Singapore, Australia, New Zealand, Hong Kong, Thailand, and Taiwan) Forecast to 2032
 Market Report I 2025-04-21 I 146 Pages
U.S. Automotive LED Lighting Market Research Report by Vehicle Type (Passenger Cars, Light Commercial Vehicles (LCVs) and Heavy Commercial Vehicles (HCVs)) by Adaptive Lighting (Front Adaptive Lighting, Rear Adaptive Lighting, and Ambient Adaptive Lighting) Forecast to 2032
 Market Report I 2025-04-21 I 152 Pages

Don't forget we can help save time with your search, contact us and we'll prepare and send options

North America MV-105 Cable Market Research Report by Voltage (Upto 5kV, 15kV, 25 kV and 35kV), by Jacket Type (PVC (polyvinyl chloride) jacket CPE (Chlorinated Polyethylene) Jacket, HDPE (High Density Polyethylene Jacket), PE (Polyethylene) Jacket, XLPE (Cross-Linked Polyethylene) Jacket and others), by Insulation Type (XLPE (Cross-Linked Polyethylene), EPR (Ethylene Propylene Rubber) and others), by Material (Copper and Aluminium), by End Use (Industrial, Energy & Power, Oil & Gas, Aerospace & Defence, It & Telecommunication, Commercial and Others) Forecast to 2035
 Market Report I 2025-04-21 I 114 Pages
Africa Palm Oil Market Research Report Information by Type (Crude Palm Oil, RBD Palm Oil, Palm Kernel Oil and Fractionated Palm Oil), by Application (Edible Oil, Bio-Diesel, Lubricants, Cosmetics and Others) Forecast to 2032
 Market Report I 2025-04-21 I 103 Pages